Search research articles
Contact Us
Filters
Showing results (41-50 of 99) with videos related to
Page
of 10
Sort By:
Clinical and Experimental Immunology
|
March 1, 1990
The effect of the immunomodulator agent AS101 on interleukin-2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibody
M Blank, B Sredni, M Albeck, et al.
Archives of Toxicology
|
January 1, 1989
Toxicity study in rats of a tellurium based immunomodulating drug, AS-101: a potential drug for AIDS and cancer patients
A Nyska, T Waner, M Pirak, et al.
Experimental Hematology
|
November 1, 1990
Enhancing effect of cyclosporins A and G on bone marrow colony formation
Y Kalechman, B Sredni, R R Caspi, et al.
Journal of Clinical Immunology
|
September 1, 1988
Production of and response to interleukin-2 in Graves' disease
Z Eisenstein, E Engelsman, M Weiss, et al.
International Journal of Oncology
|
May 5, 2011
Inhibition of B16 melanoma metastasis by the immunomodulator AS101
R Xu, Y Kalechman, M Albeck, et al.
Blood
|
March 15, 1995
Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate
Y Kalechman, A Zuloff, M Albeck, et al.
Natural Immunity and Cell Growth Regulation
|
January 1, 1990
Spontaneous release of a factor with interleukin-3-like activity by human lymphocytes and monocytes
P Fishman, M Djaldetti, S Grossman, et al.
Immunopharmacology
|
March 1, 1996
Photofrin II induces cytokine secretion by mouse spleen cells and human peripheral mononuclear cells
S Herman, Y Kalechman, U Gafter, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1982
Defective regulation of B lymphocyte colony formation in patients with systemic lupus erythematosus
S Kumagai, B Sredni, S House, et al.
European Journal of Pharmacology
|
June 5, 1997
Essential fatty acid preparation improves biochemical and cognitive functions in experimental allergic encephalomyelitis rats
S Yehuda, S Rabinovitz, D I Mostofsky, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 99) with videos related to
Sort By:
Page
of 10
Clinical and Experimental Immunology
|
March 1, 1990
The effect of the immunomodulator agent AS101 on interleukin-2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibody
M Blank, B Sredni, M Albeck, et al.
Archives of Toxicology
|
January 1, 1989
Toxicity study in rats of a tellurium based immunomodulating drug, AS-101: a potential drug for AIDS and cancer patients
A Nyska, T Waner, M Pirak, et al.
Experimental Hematology
|
November 1, 1990
Enhancing effect of cyclosporins A and G on bone marrow colony formation
Y Kalechman, B Sredni, R R Caspi, et al.
Journal of Clinical Immunology
|
September 1, 1988
Production of and response to interleukin-2 in Graves' disease
Z Eisenstein, E Engelsman, M Weiss, et al.
International Journal of Oncology
|
May 5, 2011
Inhibition of B16 melanoma metastasis by the immunomodulator AS101
R Xu, Y Kalechman, M Albeck, et al.
Blood
|
March 15, 1995
Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate
Y Kalechman, A Zuloff, M Albeck, et al.
Natural Immunity and Cell Growth Regulation
|
January 1, 1990
Spontaneous release of a factor with interleukin-3-like activity by human lymphocytes and monocytes
P Fishman, M Djaldetti, S Grossman, et al.
Immunopharmacology
|
March 1, 1996
Photofrin II induces cytokine secretion by mouse spleen cells and human peripheral mononuclear cells
S Herman, Y Kalechman, U Gafter, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1982
Defective regulation of B lymphocyte colony formation in patients with systemic lupus erythematosus
S Kumagai, B Sredni, S House, et al.
European Journal of Pharmacology
|
June 5, 1997
Essential fatty acid preparation improves biochemical and cognitive functions in experimental allergic encephalomyelitis rats
S Yehuda, S Rabinovitz, D I Mostofsky, et al.
Page
of 10